Form D — BioLineRx Ltd.

0001178913-26-004469 · filed Sep 9, 2026

Offering amounts describe securities offered; amounts sold are issuer-reported as of each filing. Amendments can repeat earlier amounts. We do not add these figures into a capital-raised total. Missing amounts are not zero. Data coverage and methodology · How to interpret the amounts.

Check this disclosure on SEC EDGAR · More Biotechnology filings

Offering

Industry: Biotechnology
Exemptions: 06b
Reported offering amount: $3,750,000
Reported amount sold: $3,750,000
Minimum investment: $0
Investors: 1
Sales commission: $262,500
Finders' fees: $0

Issuer

Name: BioLineRx Ltd.
CIK: 1498403
Entity: Corporation
Jurisdiction: ISRAEL
Year incorporated: —
Address: 2 HAMA'AYAN STREET
MODI'IN, L3 7177871
Phone: 972-8-642-9100

Related persons

May not be accurate — issuers self-report this list and the SEC does not verify it. Cross-check the original SEC EDGAR filing if accuracy matters.

Philip A. Serlin · Executive Officer

Modi'in, L3 Find on LinkedIn ↗
Mali Zeevi · Executive Officer

Modi'in, L3 Find on LinkedIn ↗
Ella Sorani · Executive Officer

Modi'in, L3 Find on LinkedIn ↗
Aharon Schwartz · Director

Modi'in, L3 Find on LinkedIn ↗
Rami Dar · Director

Modi'in, L3 Find on LinkedIn ↗
BJ Bormann · Director

Modi'in, L3 Find on LinkedIn ↗
Raphael Hofstein · Director

Modi'in, L3 Find on LinkedIn ↗
Avraham Molcho · Director

Modi'in, L3 Find on LinkedIn ↗
Sandra Panem · Director

Modi'in, L3 Find on LinkedIn ↗
Shaoyu Yan · Director

Modi'in, L3 Find on LinkedIn ↗
Gal Cohen · Director

Modi'in, L3 Find on LinkedIn ↗

View the original filing on SEC EDGAR ↗